Skoči na glavni sadržaj

Pregledni rad

https://doi.org/10.20471/LO.2018.46.02-03.15

Optimal treatment of patients with high-risk prostate cancer

Katarina Antunac orcid id orcid.org/0000-0002-8356-9897 ; Division of Radiotherapy and Medical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia


Puni tekst: engleski pdf 311 Kb

str. 88-94

preuzimanja: 496

citiraj


Sažetak

Treatment options in subset of patients with high-risk prostate cancer are various: radical prostatectomy, hormonal therapy, radiation therapy, combined modality approach, addition of chemotherapy. Based on randomised trials data, optimal approach would consist of radical radiotherapy and long term hormonal therapy. If technically possible high dose radiotherapy, hypofractionation, image guided radiotherapy, simultaneous integrated boost on dominant intraprostatic lesion and HDR brachytherapy boost should be used as well.

Ključne riječi

high risk prostate cancer; radiotherapy; hormonal therapy; dose escalation; hypofractionation; simultaneous integrated boost

Hrčak ID:

217800

URI

https://hrcak.srce.hr/217800

Datum izdavanja:

29.1.2019.

Podaci na drugim jezicima: hrvatski

Posjeta: 1.712 *